What is OpenClinica?
OpenClinica provides a secure software-as-a-service platform designed to automate data acquisition, thereby streamlining the clinical trial process. Its technology is utilized by leading life science companies, academic institutions, and government bodies worldwide. The platform has supported thousands of studies, involving millions of patients, and serves a broad spectrum of research organizations across biotech, pharmaceuticals, medical device manufacturing, and contract research organizations. This extensive adoption highlights OpenClinica's critical role in modern medical research infrastructure.
How much funding has OpenClinica raised?
OpenClinica has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for OpenClinica?
With a substantial total funding amount and recent capital infusion, OpenClinica is positioned for continued expansion and innovation in the clinical trial technology sector. The company's focus on automating data acquisition and ensuring data integrity aligns with the increasing demands for efficiency and reliability in late-stage clinical research. Future strategic initiatives are likely to involve further platform enhancements, broader market penetration, and deeper integration with healthcare data ecosystems to support the development of new therapies and medical advancements.
See full OpenClinica company page
